Company intelligence / Profile preview
Freya Biosciences
Copenhagen, Denmarkfreyabiosciences.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Phase 1
01
Overview
Freya Biosciences has reported positive topline results from its first Phase 1 study of FB101, an investigational vaginal microbial immunotherapeutic. The company’s DYSCOVER™ platform has yielded promising candidates such as FB301 for improving pregnancy success rates in IVF. The company is advancing programs targeting bacterial vaginosis to prevent preterm birth and address other maternal health indications. Recent investments from the Bill & Melinda Gates Foundation validate their approach and support further development of their pipeline.[3][5]
- Therapeutic areas
- Infectious DiseasesWomen's Health
- Modalities
- Microbial immunotherapies[1][2][5]Live biotherapeutics (Lactobacillus strains)[2]
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Bill & Melinda Gates Foundation – strategic investment partnership focused on maternal/newborn health via BV/preterm birth therapies.[2]
Beyond the preview
Go deeper on Freya Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Freya Biosciences.